Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2003
06/03/2003US6573047 Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation
06/03/2003US6573045 Reporter molecule and RNA target molecule, both carrying a fluorescent or chromogenic group, placed in close proximity to each other; addition of test compound inhibits their binding and increases fluorescence; drug screening
06/03/2003US6573043 Correlating cellular morphology with presence of target nucleic acid sequence by staining and hybridizing with fluorescently labeled nucleic acid probe; use in prognostic, diagnostic, or research applications
06/03/2003US6573042 In situ hybridization of cells using nucleic acid probe which selectively hybridizes to one aneuploid chromosome
06/03/2003US6573039 Automated method for analyzing translocation of a protein between nucleus and cytoplasm using fluorescent reporter molecules; use in drug screening
06/03/2003US6572864 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
06/03/2003US6572862 Methods and reagents to detect and characterize Norwalk and related viruses
06/03/2003US6572822 Visual blood glucose test strip
06/03/2003CA2220418C Oligonucleotide sizing using cleavable primers
06/03/2003CA2185574C Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
05/2003
05/30/2003WO2003044532A1 Method for detecting analyte(s) using magnetic colloidal particles
05/30/2003WO2003044529A1 Modulators of lymphocyte activation, mkk3b compositions and methods of use
05/30/2003WO2003044528A2 Flow-controlled magnetic particle manipulation
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044511A2 Construction and use of micro-electrode arrays
05/30/2003WO2003044486A2 Early leukemia diagnostics using microsphere arrays
05/30/2003WO2003044481A2 Optical bio-discs and microfluidic devices for analysis of cells
05/30/2003WO2003044232A1 Method of detection of prostate cancer
05/30/2003WO2003044231A1 Method and kit for proximity probing with multivalent proximity probes
05/30/2003WO2003044230A1 Method and kit for detection of novel pathogen inhibitors
05/30/2003WO2003044229A1 Nucleic acid enrichment
05/30/2003WO2003044228A1 Improved primer discrimination method in allele-specific primer extension
05/30/2003WO2003044226A2 Method and nucleic acids for the analysis of a lymphoid cell proliferative disorder
05/30/2003WO2003044225A2 Profiling of the immune gene repertoire
05/30/2003WO2003044223A2 Phosphine-containing formulations for chemiluminescent luciferase assays
05/30/2003WO2003044222A1 Atp measurement method allowing visual judgement and reagent therefor
05/30/2003WO2003044220A1 Total cysteine assay
05/30/2003WO2003044219A1 Method of flexibly generating diverse reaction chemistries
05/30/2003WO2003044217A2 Automated sample preparation methods and devices
05/30/2003WO2003044216A2 Multiplex oligonucleotide addition and target amplification
05/30/2003WO2003044215A2 Methods for evaluating drug-resistance gene expression in the cancer patient
05/30/2003WO2003044214A2 Methods and compositions in checkpoint signaling
05/30/2003WO2003044213A2 Cell and tissue arrays and microarrays and methods of use
05/30/2003WO2003044211A2 Materials and methods for releasing genetic material
05/30/2003WO2003044205A1 Method for production of asymmetric carotenoids
05/30/2003WO2003044202A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003WO2003044195A1 Method of amplifying target single-stranded nucleic acid fragment
05/30/2003WO2003044187A2 Emulsion compositions
05/30/2003WO2003044178A2 Hybrid oligonucleotide primers for amplification of dna and uses thereof
05/30/2003WO2003044177A2 Multiplex pcr
05/30/2003WO2003044176A2 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044161A2 Gene amplification and overexpression in cancer
05/30/2003WO2003044049A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003WO2003044039A2 Atrial natriuretic peptide clearance receptor variant associated with bone disorders
05/30/2003WO2003044036A1 Tumor specific monoclonal antibodies
05/30/2003WO2003043978A2 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003043568A2 Compositions and methods for the suppression of mammary epithelial cell proliferation
05/30/2003WO2003043487A2 Method of using a non-antibody protein to detect and measure an analyte
05/30/2003WO2003043403A2 Methods and apparatus for blood typing with optical bio-discs
05/30/2003WO2003043402A2 Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
05/30/2003WO2003025204A3 Biochip assembly, sensor assembly and method for operating a biochip assembly
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003014721A3 Chimeric protein and its use in electron transfer methods
05/30/2003WO2003014341A3 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof
05/30/2003WO2003011768A3 Microfluidic device for molecular analysis
05/30/2003WO2003008979A3 Method to purify prion protein using nuclease
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003002759A3 Detection of specific dinucleotides in dna-samples by fluorescence resonance energy transfer (fret)
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002101081A3 Method for assessing the virulence of pathogens and uses thereof
05/30/2003WO2002098891A3 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
05/30/2003WO2002097119A3 Use of the indication of the expression of splice variants of gene 21 for the diagnosis and treatment of tumour diseases
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002095363A3 Methods for attenuation of virulence in bacteria
05/30/2003WO2002094982A3 Increasing bioavailability of carotenoids
05/30/2003WO2002092776A3 Methods for the indentification of inhibitors of 2-hydroxyisoflavone reductase expression or activity in plants
05/30/2003WO2002089829A3 Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer
05/30/2003WO2002079786A3 Method for identifying drugs for the treatment of type ii diabetes
05/30/2003WO2002077603A3 Identification and enumeration of coccidial sporocysts
05/30/2003WO2002077285A3 Methods of determining the presence of polynucleotides employing amplification
05/30/2003WO2002073196A3 Individualization of therapy with antipsychotics
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002070738A3 Diagnosis and treatment of blood disorders
05/30/2003WO2002066678A3 Security system
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002061114A3 Water-soluble, fluorescent and mobile peptide substrates
05/30/2003WO2002054450A3 Method of patterning a mask on the surface of a substrate and product manufactured thereby
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof
05/30/2003WO2002044339A3 Nucleic acid amplification methods
05/30/2003WO2002040710A3 Method for detecting methylation states for a toxicological diagnostic
05/30/2003WO2002038729A9 GENE MONITORING AND GENE IDENTIFICATION USING cDNA ARRAYS
05/30/2003WO2002038608A9 Methods of screening for ltrpc2 modulators
05/30/2003WO2002036816A3 Method of determining susceptibility to diseases
05/30/2003WO2002033118A3 Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
05/30/2003WO2002029091A3 Methods and compositions for the treatment of inflammatory diseases
05/30/2003WO2002027026A3 Improved support for solid phase hybridization assays
05/30/2003WO2002024948A3 HOMOZYGOUS DELETION OF CHROMOSOME 8p23 IN HEPATOCELLULAR CARCINOMA
05/30/2003WO2002014862A3 Method and device for characterising and/or for detecting a bonding complex
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001079543A3 Assay for identification of target rna binding compounds
1 ... 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 ... 3003